ENDEFR
Home › Czechia › Česká lékárnická, a.s.

Česká lékárnická, a.s.

Akciová společnost · Ostrava, Czechia · LEI 31570048XD1UL7THW250
LEI activegroup parent

Summary

Česká lékárnická, a.s. is registered in Czechia and entered in the “Commercial Register (Obchodní rejstřík)” under number 63080877. Its legal form is Akciová společnost – public limited company (Czechia). Česká lékárnická, a.s. is the ultimate parent of a group of 1 subsidiary in 1 country, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by legal entities that are not subject to accounting consolidation. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 19 Jul 2023 and the record was last updated on 15 Jul 2026; the next renewal is due by 21 Jul 2027. GLEIF's ISIN mapping lists 1 ISIN for this LEI.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formAkciová společnost
public limited company (Czechia)
RegisterCommercial Register (Obchodní rejstřík) · Register website
Registration number63080877
Registration authorityMinistry of Justice
JurisdictionCzechia
Registered addressTěšínská 1349/296, 716 00 Ostrava, Czechia
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)15 Aug 1995
LEI31570048XD1UL7THW250
LEI statusactive
LEI first issued19 Jul 2023
LEI record last updated15 Jul 2026
Next LEI renewal21 Jul 2027
Corroboration of the LEI recordfully corroborated

Group membership

Česká lékárnická, a.s. this entity
PHARMOS, a.s. Czechia

Parent not reported to GLEIF

  • Direct parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
  • Ultimate parent: the entity is controlled by legal entities that are not subject to accounting consolidation.

Direct subsidiaries (1)

ISINs mapped to this LEI (1)

CZ0009012779

1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.